Six months of COVID vaccines: what 1.7 billion doses have taught scientists
Top Cited Papers
- 4 June 2021
- journal article
- other
- Published by Springer Science and Business Media LLC in Nature
- Vol. 594 (7862), 164-167
- https://doi.org/10.1038/d41586-021-01505-x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in AdolescentsThe New England Journal of Medicine, 2021
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 VariantsThe New England Journal of Medicine, 2021
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19The New England Journal of Medicine, 2021
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 VariantThe New England Journal of Medicine, 2021
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantThe New England Journal of Medicine, 2021
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7Published by Cold Spring Harbor Laboratory ,2021
- Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA Covid-19 Vaccine in long-term care facility residents and healthcare workers – a Danish cohort studyPublished by Cold Spring Harbor Laboratory ,2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020